tirzepatide direct from manufacturer Lilly launches lower-price weight-loss drug Zepbound without injector pen Tirzepatide (Mounjaro) In Sherman Oaks
Description
Food and Drug Administration (FDA) approved to reduce A1C levels in individuals with type 2 diabetes
Both drugs can be costly without insurance, but savings programs are available
Your clinician will help determine which option aligns best with your profile
Statements Author contributions FZ wrote the manuscript
Its essential to keep an eye on your blood sugar levels and to drink responsibly
This process doesn't need you to log every meal or activity
